Gabapentin or Pregabalin for Both RLS and Insomnia
For a patient with both restless legs syndrome and insomnia, use gabapentin (starting 1200-1800 mg) or pregabalin (starting 150-300 mg) taken 1-2 hours before bedtime, as these alpha-2-delta ligands are the only medications with strong evidence for treating RLS while simultaneously improving sleep quality. 1
Why Alpha-2-Delta Ligands Are the Answer
The 2025 American Academy of Sleep Medicine guidelines represent a major shift in RLS treatment, now giving strong recommendations (moderate certainty evidence) for three agents as first-line therapy 1:
- Gabapentin enacarbil (extended-release formulation)
- Gabapentin (immediate-release)
- Pregabalin
These medications uniquely address both conditions because they:
- Directly treat RLS symptoms without risk of augmentation (worsening of symptoms over time)
- Possess inherent sedating properties that improve sleep initiation and maintenance
- Improve subjective sleep quality beyond just treating RLS 2, 3
What NOT to Use (Critical Pitfalls)
Avoid Dopamine Agonists as Standard Treatment
The 2025 guidelines now suggest against standard use of all dopamine agonists 1:
- Pramipexole (conditional recommendation, moderate certainty)
- Ropinirole (conditional recommendation, moderate certainty)
- Rotigotine patch (conditional recommendation, low certainty)
- Levodopa (conditional recommendation, very low certainty)
Why this matters: These agents cause augmentation in 30-70% of patients with long-term use, paradoxically worsening RLS symptoms and creating a treatment trap 4, 2, 5. While they may help RLS short-term, they worsen insomnia through augmentation and have no direct sleep-promoting effects.
Avoid Benzodiazepines
The guidelines suggest against clonazepam for RLS (conditional recommendation, very low certainty) 1. While one older study showed clonazepam improved subjective sleep quality in RLS patients 3, it failed to reduce the actual periodic limb movements and carries risks of dependence, cognitive impairment, falls (especially in older adults), and dementia with chronic use 6. A 2017 Cochrane review found no adequate evidence supporting benzodiazepines for RLS 7.
Practical Dosing Algorithm
Step 1: Start with Gabapentin or Pregabalin
- Gabapentin: Start 300 mg 2 hours before bedtime, titrate by 300 mg every 3-5 days to target 1200-1800 mg (can go up to 2400 mg if needed)
- Pregabalin: Start 75 mg 1-2 hours before bedtime, titrate by 75 mg every 3-5 days to target 150-300 mg (can go up to 450 mg if needed)
- Gabapentin enacarbil: 600 mg once daily at 5 PM with food (extended-release formulation with better bioavailability)
Step 2: Check and Correct Iron Status FIRST Before or concurrent with medication, check ferritin and transferrin saturation. The guidelines give a strong recommendation for IV ferric carboxymaltose if ferritin <75 ng/mL or transferrin saturation <20% 1. Iron correction alone may resolve symptoms and reduce medication needs.
Step 3: Monitor for Side Effects
- Sedation and dizziness are common initially but often improve 2
- Start low, go slow, especially in elderly patients
- Take with food to reduce GI upset
When Other Options Apply
Opioids (Extended-Release Oxycodone): The guidelines suggest their use (conditional recommendation, moderate certainty) 1, but reserve these for refractory cases unresponsive to alpha-2-delta ligands. Recent registry data shows reassuring safety when properly monitored 8, but they remain second-line due to addiction potential and regulatory concerns.
Dopamine Agonists: May be used only for short-term, intermittent use in patients who prioritize immediate symptom relief over long-term safety and accept augmentation risk 1. This means occasional use (1-2 times weekly), not daily therapy.
The Insomnia Evidence Gap
The 2016 insomnia guidelines found that eszopiclone, zolpidem, and suvorexant improved short-term sleep outcomes 6, but these agents do not treat RLS and may worsen symptoms. The evidence for most sleep medications in older adults was insufficient 6, and observational data linked chronic hypnotic use to dementia, fractures, and major injury 6.
Bottom line: No traditional "sleep medication" treats both conditions. Only alpha-2-delta ligands address the root cause (RLS) while providing sleep benefits as a secondary effect.